This document provides the education and professional experience of Nicholas S. Patapis. It includes:
- His doctorate in psychology from Widener University and other relevant degrees and training.
- Over 15 years of experience as a clinical psychologist conducting evaluations, psychotherapy, and research focused on substance abuse and forensic psychology.
- Positions held include positions at the University of Pennsylvania, private practice, and director roles overseeing clinical programs.
- Extensive research experience including roles on multiple NIH-funded grants studying topics like drug courts, internet drug availability, and ethics in substance abuse research.
A great presentation from a well versed friend in research and EBM, Dr Yaser Faden.
This is a simple introduction to study design with an accompanying workshop to simplify the different types of research study designs.
Past nonmedical opioid use could predict future heroin use among teensΔρ. Γιώργος K. Κασάπης
Two studies published yesterday point to predictors of teens using drugs. Researchers in one study found that teens who used opioids when they were not prescribed for medical reasons were more likely to later use heroin. Of the nearly 3,300 high schoolers who were included in the study, those who previously used opioids were about 11% more likely to use heroin, while those who currently used opioids were about 13% more likely to use heroin.
Another study found that there was no increase in teenagers using marijuana if they lived in a state that had laws legalizing the drug. In fact, in states with recreational marijuana laws, the odds of teen marijuana use were about 10% less following legalization.
Observational analytical study: Cross-sectional, Case-control and Cohort stu...Prabesh Ghimire
This presentation provides overview of three observational analytical studies: cross-sectional study design, case-control study design and cohort study design
PCOMS and an Acute Care Inpatient Unit: Quality Improvement and Reduced Readm...Barry Duncan
High psychiatric readmission rates continue while evidence suggests that care is not perceived by patients as “patient centered.” Research has focused on aftercare strategies with little attention to the inpatient treatment itself as an intervention to reduce readmission rates. Quality improvement strategies based on patient-centered care may offer an alternative. We evaluated outcomes and readmission rates using a benchmarking methodology with a naturalistic data set from an inpatient psychiatric facility (N 2,247) that used a quality-improvement strategy called systematic patient feedback. A systematic patient feedback system, the Partners for Change Outcome Management System (PCOMS), was used. Overall pre-post effect sizes were d 1.33 and d 1.38 for patients diagnosed with a mood
disorder. These effect sizes were statistically equivalent to RCT benchmarks for feedback and depression.
Readmission rates were 6.1% (30 days), 9.5% (60 days), and 16.4% (180 days), all lower than national benchmarks. We also found that patients who achieved clinically significant treatment outcomes were less likely to be readmitted. We tentatively suggest that a focus on real-time patient outcomes as well as care that is “patient centered” may provide lower readmission rates.
A great presentation from a well versed friend in research and EBM, Dr Yaser Faden.
This is a simple introduction to study design with an accompanying workshop to simplify the different types of research study designs.
Past nonmedical opioid use could predict future heroin use among teensΔρ. Γιώργος K. Κασάπης
Two studies published yesterday point to predictors of teens using drugs. Researchers in one study found that teens who used opioids when they were not prescribed for medical reasons were more likely to later use heroin. Of the nearly 3,300 high schoolers who were included in the study, those who previously used opioids were about 11% more likely to use heroin, while those who currently used opioids were about 13% more likely to use heroin.
Another study found that there was no increase in teenagers using marijuana if they lived in a state that had laws legalizing the drug. In fact, in states with recreational marijuana laws, the odds of teen marijuana use were about 10% less following legalization.
Observational analytical study: Cross-sectional, Case-control and Cohort stu...Prabesh Ghimire
This presentation provides overview of three observational analytical studies: cross-sectional study design, case-control study design and cohort study design
PCOMS and an Acute Care Inpatient Unit: Quality Improvement and Reduced Readm...Barry Duncan
High psychiatric readmission rates continue while evidence suggests that care is not perceived by patients as “patient centered.” Research has focused on aftercare strategies with little attention to the inpatient treatment itself as an intervention to reduce readmission rates. Quality improvement strategies based on patient-centered care may offer an alternative. We evaluated outcomes and readmission rates using a benchmarking methodology with a naturalistic data set from an inpatient psychiatric facility (N 2,247) that used a quality-improvement strategy called systematic patient feedback. A systematic patient feedback system, the Partners for Change Outcome Management System (PCOMS), was used. Overall pre-post effect sizes were d 1.33 and d 1.38 for patients diagnosed with a mood
disorder. These effect sizes were statistically equivalent to RCT benchmarks for feedback and depression.
Readmission rates were 6.1% (30 days), 9.5% (60 days), and 16.4% (180 days), all lower than national benchmarks. We also found that patients who achieved clinically significant treatment outcomes were less likely to be readmitted. We tentatively suggest that a focus on real-time patient outcomes as well as care that is “patient centered” may provide lower readmission rates.
Running head MENTAL HEALTH IN LAW ENFORCEMENT1MENTAL HEALTH IN.docxglendar3
Running head: MENTAL HEALTH IN LAW ENFORCEMENT 1
MENTAL HEALTH IN LAW ENFORCEMENT 4
Mental Health in Law EnforcementIndya KamaraSaint Leo University
I. The Problem
Mental health is an increasing problem in law enforcement. While mental illnesses may not be a direct correlation to crimes that are committed, offenders are found populating the jails and prisons (Peterson, 2014). When offenders are arrested and jailed for the crimes that they commit, through experience in the field, they are under-treated for mental illnesses.
II. Factors Bearing the Problem
The bearing factors comes in many forms as there can be many different things that play a role in the under-treatment of mental illnesses in offenders in the law enforcement realm. Evans, Huang, & Hser (2011) argues that the contributing factors to mentally ill offenders being under-treated are due to the lack of assessments of mental health needs, trained professionals, and lack of multiple locations to treat those who are struggling with mental illnesses.
i. The behaviors that offenders exhibit are at times overlooked by law enforcement officials on a whole. Law enforcement officials are not recognizing the behaviors of offenders that exhibit the characteristics of being mentally ill as it comes in different forms with different people. There are many officers that are not aware of mental health illnesses which they may need additional training recognizing the behavioral signs and symptoms.
ii. Due to the lack of training an officer may receive, they may miss the behavioral sign or symptoms and are unable to properly assess offender’s needs. Officer’s inability to assess what an offender’s needs are puts them at a disadvantage to offer treatment versus putting them in the jail environment untreated. Many times, offenders are not assessed for mental illnesses unless they are suspected of having symptoms of mental illnesses and are committed involuntarily by an officer or voluntarily on their own in an effort of seeking help. In many cases, offenders are transported to jail instead of a psychiatric facility to seek help for that offender.
iii. While offenders are in their mental illness state, they are oftentimes unaware of what is happening to them to request the help that they need. On the other hand, some offenders may be aware of what may be wrong with them and are in denial so they fail to accept treatment.
iv. Withholding medications that have successfully managed patient symptoms are also an issue with the jail system. Individuals may have encounters with the law due to stopping medications and instead of patients being restarted on medications that keep them regulated, those medications such as antipsychotic medications continue to be withheld in the correctional facilities. Thereby, continuing the cycle of mismanagement of behavioral health issues.
References
Evans, E., Huang, D., & Hser, Y. (2011). High-risk offenders participating in court-sup.
Running head MENTAL HEALTH IN LAW ENFORCEMENT1MENTAL HEALTH IN.docxtodd581
Running head: MENTAL HEALTH IN LAW ENFORCEMENT 1
MENTAL HEALTH IN LAW ENFORCEMENT 4
Mental Health in Law EnforcementIndya KamaraSaint Leo University
I. The Problem
Mental health is an increasing problem in law enforcement. While mental illnesses may not be a direct correlation to crimes that are committed, offenders are found populating the jails and prisons (Peterson, 2014). When offenders are arrested and jailed for the crimes that they commit, through experience in the field, they are under-treated for mental illnesses.
II. Factors Bearing the Problem
The bearing factors comes in many forms as there can be many different things that play a role in the under-treatment of mental illnesses in offenders in the law enforcement realm. Evans, Huang, & Hser (2011) argues that the contributing factors to mentally ill offenders being under-treated are due to the lack of assessments of mental health needs, trained professionals, and lack of multiple locations to treat those who are struggling with mental illnesses.
i. The behaviors that offenders exhibit are at times overlooked by law enforcement officials on a whole. Law enforcement officials are not recognizing the behaviors of offenders that exhibit the characteristics of being mentally ill as it comes in different forms with different people. There are many officers that are not aware of mental health illnesses which they may need additional training recognizing the behavioral signs and symptoms.
ii. Due to the lack of training an officer may receive, they may miss the behavioral sign or symptoms and are unable to properly assess offender’s needs. Officer’s inability to assess what an offender’s needs are puts them at a disadvantage to offer treatment versus putting them in the jail environment untreated. Many times, offenders are not assessed for mental illnesses unless they are suspected of having symptoms of mental illnesses and are committed involuntarily by an officer or voluntarily on their own in an effort of seeking help. In many cases, offenders are transported to jail instead of a psychiatric facility to seek help for that offender.
iii. While offenders are in their mental illness state, they are oftentimes unaware of what is happening to them to request the help that they need. On the other hand, some offenders may be aware of what may be wrong with them and are in denial so they fail to accept treatment.
iv. Withholding medications that have successfully managed patient symptoms are also an issue with the jail system. Individuals may have encounters with the law due to stopping medications and instead of patients being restarted on medications that keep them regulated, those medications such as antipsychotic medications continue to be withheld in the correctional facilities. Thereby, continuing the cycle of mismanagement of behavioral health issues.
References
Evans, E., Huang, D., & Hser, Y. (2011). High-risk offenders participating in court-sup.
NursingResearchMethods and CriticalAppraisal for Escoutsgyqmo
Nursing
Research
Methods and Critical
Appraisal for Evidence-Based
Practice
NINETH EDITION
Geri LoBiondo-Wood, PhD, RN,
FAAN
Professor and Coordinator, PhD in Nursing Program, University of Texas
Health Science Center at Houston, School of Nursing, Houston, Texas
Judith Haber, PhD, RN, FAAN
2
The Ursula Springer Leadership Professor in Nursing, New York
University, Rory Meyers College of Nursing, New York, New York
3
Table of Contents
Cover image
Title page
Copyright
About the authors
Contributors
Reviewers
To the faculty
To the student
Acknowledgments
I. Overview of Research and Evidence-Based
Practice
Introduction
4
kindle:embed:0006?mime=image/jpg
References
1. Integrating research, evidence-based practice, and quality
improvement processes
References
2. Research questions, hypotheses, and clinical questions
References
3. Gathering and appraising the literature
References
4. Theoretical frameworks for research
References
II. Processes and Evidence Related to Qualitative
Research
Introduction
References
5. Introduction to qualitative research
References
6. Qualitative approaches to research
References
7. Appraising qualitative research
5
Critique of a qualitative research study
References
References
III. Processes and Evidence Related to
Quantitative Research
Introduction
References
8. Introduction to quantitative research
References
9. Experimental and quasi-experimental designs
References
10. Nonexperimental designs
References
11. Systematic reviews and clinical practice guidelines
References
12. Sampling
References
13. Legal and ethical issues
References
6
14. Data collection methods
References
15. Reliability and validity
References
16. Data analysis: Descriptive and inferential statistics
References
17. Understanding research findings
References
18. Appraising quantitative research
Critique of a quantitative research study
Critique of a quantitative research study
References
References
References
IV. Application of Research: Evidence-Based
Practice
Introduction
References
19. Strategies and tools for developing an evidence-based practice
References
7
20. Developing an evidence-based practice
References
21. Quality improvement
References
Example of a randomized clinical trial (Nyamathi et al., 2015)
Nursing case management peer coaching and hepatitis A and B
vaccine completion among homeless men recently released on
parole
Example of a longitudinal/Cohort study (Hawthorne et al., 2016)
Parent spirituality grief and mental health at 1 and 3 months after
their infant schild s death in an intensive care unit
Example of a qualitative study (van dijk et al., 2015) Postoperative
patients perspectives on rating pain: A qualitative study
Example of a correlational study (Turner et al., 2016) Psychological
functioning post traumatic growth and coping in parents and
siblings of adolescent cancer survivors
Example of a systematic Review/Met ...
Data stratification is the process of partitioning the data into distinct and non-overlapping groups since the
study population consists of subpopulations that are of particular interest. In clinical data, once the data is
stratified into sub populations based on a significant stratifying factor, different risk factors can be
determined from each subpopulation. In this paper, the Fisher’s Exact Test is used to determine the
significant stratifying factors. The experiments are conducted on a simulated study and the Medical,
Epidemiological and Social Aspects of Aging (MESA) data constructed for prediction of urinary
incontinence. Results show that, smoking is the most significant stratifying factor of MESA data, showing
that the smokers and non-smokers indicates different risk factors towards urinary incontinence and should
be treated differently.
Hospital Care for Mental Health and Substance Abuse ConditionsLizbethQuinonez813
Hospital Care for Mental Health and Substance Abuse Conditions in
Parkinson’s Disease
Allison. W. Willis, MD, MSCI,1,2,3,4* Dylan P. Thibault, MS,1 Peter N. Schmidt, PhD,5 E. Ray Dorsey, MD, MBA,6 and
Daniel Weintraub, MD1,7,8
1Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
2
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
3
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
4
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
5
National Parkinson’s Foundation, Miami, Florida, USA
6Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
7
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
8
Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia,
Pennsylvania, USA
A B S T R A C T : O b j e c t i v e : The objective of this
study was to examine mental health conditions among
hospitalized individuals with Parkinson’s disease in the
United States.
M e t h o d s : This was a serial cross-sectional study of
hospitalizations of individuals aged �60 identified in the
Nationwide Inpatient Sample dataset from 2000 to
2010. We identified all hospitalizations with a diagnosis
of PD, alcohol abuse, anxiety, bipolar disorder, depres-
sion, impulse control disorders, mania, psychosis, sub-
stance abuse, and attempted suicide/suicidal ideation.
National estimates of each mental health condition
were compared between hospitalized individuals with
and without PD. Hierarchical logistic regression models
determined which inpatient mental health diagnoses
were associated with PD, adjusting for demographic,
payer, geographic, and hospital characteristics.
R e s u l t s : We identified 3,918,703 mental health and sub-
stance abuse hospitalizations. Of these, 2.8% (n 5 104,
437) involved a person also diagnosed with PD. The major-
ity of mental health and substance abuse patients were
white (86.9% of PD vs 83.3% of non-PD). Women were
more common than men in both groups (male:female
prevalence ratio, PD: 0.78, 0.78-0.79, non-PD: 0.58, 0.57-
0.58). Depression (adjusted odds ratio 1.32, 1.31-1.34),
psychosis (adjusted odds ratio 1.25, 1.15-1.33), bipolar
disorder (adjusted odds ratio 2.74, 2.69-2.79), impulse
control disorders (adjusted odds ratio 1.51, 1.31-1.75),
and mania (adjusted odds ratio 1.43, 1.18-1.74) were more
likely among PD patients, alcohol abuse was less likely
(adjusted odds ratio 0.26, 0.25-0.27). We found no PD-
associated difference in suicide-related care.
C o n c l u s i o n s : PD patients have unique patterns of
acute care for mental health and substance abuse.
Research is needed to guide PD treatment in individuals
with ...
Internet Interventions In Review, In Use, and Into the Future.docxmariuse18nolet
Internet Interventions: In Review, In Use, and Into the Future
Lee M. Ritterband, Linda A. Gonder-Frederick, Daniel J. Cox, Allan D. Clifton,
Rebecca W. West, and Stephen M. Borowitz
University of Virginia Health System
The provision of health care over the Internet is a rapidly evolving and potentially beneficial means of
delivering treatment otherwise unsought or unobtainable. Internet interventions are typically behavioral
treatments operationalized and transformed for Web delivery with the goal of symptom improvement.
The literature on the feasibility and utility of Internet interventions is limited, and there are even fewer
outcome study findings. This article reviews empirically tested Internet interventions and provides an
overview of the issues in developing and/or using them in clinical practice. Future directions and
implications are also addressed. Although Internet interventions will not likely replace face-to-face care,
there is little doubt that they will grow in importance as a powerful component of successful psychobe-
havioral treatment.
With the advancement of computer technologies over the
past 20 years, a flood of new ways to communicate, provide, and
deliver psychological treatments has emerged. The Internet has the
ability to reach people all over the world and provide highly
specialized psychological interventions otherwise not sought or
obtainable. There is a new but growing literature on the use of the
Internet as a means of delivering treatment. These Internet treat-
ments are typically focused on behavioral issues, with the goal of
instituting behavior change and subsequent symptom improve-
ment. They are usually self-paced, interactive, and tailored to the
user, and they make use of the multimedia format offered by the
Internet. Individuals with computer and Internet access who use
these treatments may also overcome many of the barriers to
obtaining traditional care because they can seek such treatments at
any time, any place, and often at significantly reduced cost.
Clearly, people are using computers and the Internet in greater
frequency and with the specific purpose of obtaining mental health
information (see Crutsinger, 2000; Employment Policy Founda-
tion, 2001; Pew Research Center, 2002; Rabasca, 2000). This new
field of Internet interventions is only going to grow and expand.
The benefits are vast, as there is the potential for greater numbers
of people to receive more services than ever before. However, to
meet this potential, Internet interventions, like any other treatment,
must first demonstrate feasibility and efficacy through rigorous
scientific testing. In this article we present a critical examination of
the current state of the available literature focused on the devel-
opment and testing of these types of interventions. In addition,
issues that should be addressed when constructing Internet inter-
ventions are enumerated, followed by a discussion of possible
future directions and implications.
1. NICHOLAS S. PATAPIS, PSY.D., M.S.C.P.
LICENSED PSYCHOLOGIST
1535 S. 13TH
STREET PHILADELPHIA, PA 19147
PH. (215) 681-1147
FAX (215) 952-6869
_________________________________________________________________
EDUCATION
Post-doctoral M.S. in Clinical Psychopharmacology 9/06-06/09
Farleigh Dickinson University
NIH Clinical Research Fellow in Substance Abuse & Addictions 6/02-06/04
Treatment Research Center, Department of Psychiatry, University of Pennsylvania School of
Medicine. Mentor: Charles O’ Brien, MD PHD
Doctor of Psychology 9/97-06/02
Institute for Graduate Clinical Psychology, Widener University
APA Approved Program & Internship; Forensic Psychology Concentration & Certificate
Dissertation: “Psychopathy, Delinquency and Juvenile Transfers to Criminal Court”
Magna Cum Laude, Dual-Degree with MACJ
Master of Arts in Criminal Justice 09/99-05/02
Widener University
Master of Arts in Clinical Psychology 09/95 - 05/97
Towson University
Graduate Fellowship, Office of the Dean of Student Affairs
Bachelor of Science in Psychology, Frostburg State University (9/91 - 05/95)
Psi Chi National Honor Society in Psychology
WORK EXPERIENCE
Clinical Psychologist, Grand & Verdi, LLC 9/14/15
Psychologist Industrial Medical Associates 2/14 - 6/15
Conducted over 2,100 evaluations with full reports, 100% acceptance, no addendums or
rejections by PA Bureau of Disability Determination (BDD). Evaluations included Mental Status
examination, WAIS-IV, WISC-IV, TONI-IV, WRAT-IV, WMS-IV
Editor, The Tablet 1/13- 4/14
Official Publication of American Psychological Association Division 55
The American Society for the Advancement of Pharmacotherapy, .
Psychologist in Private Practice Miami Shores, FL 06/12-1/14
FL Lic. PY8800 (Inactive)
Psychologist in Private Practice PA 2/08-3/12
Individual Psychotherapy; Forensic Evaluation of Acceptance of Criminal Responsibility,
2. N. Patapis. 2
Amenability to Treatment, Risk of Future Dangerousness, 100% Stipulation; Contracted Provider:
PA Bureau of Disability Determination, Philadelphia Court of Common Pleas, Juvenile Division,
CIGNA
Psychologist/Module Director 12/08-10/10
Wordsworth Behavioral Health & Rehabilitation Services
Supervised a team of 3 in-house staff, 20 masters level clinicians and approximately 50 field
based therapeutic support staff. Responsible for intake Comprehensive Biopsychosocial
Evaluations and quarterly Re-evaluation for a caseload of 50-60 children/adolescents.
Research Scientist 7/04-1/08
Treatment Research Institute at the University of Pennsylvania, Division of Law & Ethics
Research.
Principal Investigator: “WebSafePhilly: Alerting Parents to Narcotics on the Net,” (Pennsylvania
Department of Health Grant #100707-T). Responsible for all monitoring of Adverse Effects and
serious Adverse Effects as well submitting quarterly progress reports to the state, the
Institutional Review Board as well as monitoring and implementing a Data Safety Management
Plan.
Grant Management Team/Clinical Director:
“Services Research on Sanctions and Rewards in Drug Court,” (NIDA Grant #R01-DA-14566). This
study evaluated the effect of cash incentives for compliance with a drug court program (e.g.,
treatment attendance, urinalysis results).
“CivilWorld: A Multi-Media-Based Abstinence and Recidivism Prevention Program In the
Philadelphia Prison System,”(NIDA grant #R01-DA-016610-01). This pilot study looked at the
acceptance and feasibility of an experimental interactive computer-based drug-relapse
prevention program (Civil World) versus treatment-as-usual (non-interactive 12-step videos).
“Narcotics on the Internet,” (NIDA Grant #R21-DA 019908). This study researched the promotion
and availability of prescription narcotics via no-prescription Internet-based pharmacies and
was the foundation for the “WebSafePhilly” grant and the “WebSafe” grant currently under
peer-review at NIH.
“Matching Services to Client Needs in Drug Court,” (NIDA Grant #R01-DA-13096). This study
examined the performance of drug court clients who were matched to high or low intensity
services (e.g., frequency of judicial status hearings) based on their level of need and risk.
Matching Services to Client Needs in Drug Court,” (NIDA Grant #R01-DA-13096 Competing
Continuation). This study built upon the findings of the original study by prospectively
matching clients to high or low intensity services based on the presence of antisocial
personality or previous treatment failure.
Improving Access to Health Care and Social Services for Offenders through the Philadelphia
Community Court,” (Pennsylvania Department of Health Grant). This study was an evaluation
of the services and outcomes of the Philadelphia Community court which serves as an
alternate venue for non-violent misdemeanor and summary offenders by providing treatment
in lieu of punishments.
“Improving the Ethics of Consent in Drug Abuse Research,” (NIDA Grant #R01-DA01673). This
study evaluated the effectiveness of an on-going Informed Consent procedure versus consent
as-usual.
3. N. Patapis. 3
“Ethics of Participant Payment in Drug Abuse Research,” (NIDA Grant #R01-DA013408). Findings
failed to identify increases in post-payment drug use after receipt of 20$ 40$ 60$ cash versus
gift certificate in a sample of patients in substance abuse treatment and significant decreases
in attrition versus TAU at 6, 9mos.
Mentor, NIH Research Placements in Drug Abuse for Under-represented Minorities. Appointed
by Drs. A Thomas McLellan and Charles O’Brien to serve as a research supervisor and mentor
to undergraduate students enrolled in the UPenn’s Pre-Graduate Research Training Program.
CLINICAL TRAINING
Post-Doctoral Fellowship 06/02-06/04
NIH Clinical Research Fellowship (CRF) in Substance Abuse and Addictions, Treatment Research
Center/Treatment Research Institute at the University of Pennsylvania
Courses: Patient Oriented Research, Advanced Statistical Analyses, Drugs and Behavior, Brain
Imaging in Substance Abuse: fMRI/BOLD, Psychopharmacology in Substance Abuse.
APAAPPROVEDINTERNSHIPS
Adult Forensic Neuropsychology 7/01-6/02
Mitchell Forensic Unit, Delaware Psychiatric Center. Conducted neuropsychological evaluations
of pre and post-adjudication offenders for multiple psycho-legal purposes (e.g., competency).
Performed triage diagnostic assessment and brief-psychotherapy for incoming detainees.
Conducted competency training.
· Tests and Measures: WAIS-III, WMS-III, TOMM, COGNISTAT, WCST, TONI
Juvenile Forensic Psychology 6/00-7/010
· Assessment & Treatment Alternatives, Inc. Diagnosis, treatment and treatment planning with
adolescents. Assessed the 'Amenability to Treatment' and 'Risk of Future Dangerousness' for
court and attorney referred adolescents. Tests and Measures: WASI, WAIS-III, RIM, TAT, MMPI,
Stanford-Benet, WRAT
INTERNSHIPS
Psychotherapy, Diagnosis & Assessment 9/99-5/00
Albert Einstein Medical Center, Department of Outpatient Psychiatry.
· Conducted short and long-term psychotherapy with adults, adolescents & children.
· Conducted psycho-diagnostic and psychological evaluations of patients referred from the
inpatient psychiatric unit.
Psychotherapy, Substance Abuse Treatment 9/98-5/99
· LaSalle University Counseling Center Provided psychotherapy to undergraduate and graduate
students with a wide range of psychological, interpersonal, behavioral and academic issues.
· Tests and Measures: MMPI-2, WAIS-III, NEO
Neuropsychology 8/97-6/98
University of Pennsylvania Hospital, Department of Physical Medicine and Rehabilitation,
Neuropsychology Service.
· Administered neuropsychological tests and measures to post-operative or post-injury patients.
· Testing and assessment was indicated to identify functional deficits in the patient's cognitive
4. N. Patapis. 4
functioning (e.g., memory, motor skills, language) subsequent to medical procedure, acute brain
injury/insult, onset or exacerbation of chronic/progressive neurological diseases.
Masters Internship: Child and Family Therapy. 8/96-6/97
Kennedy-Krieger Institute, The Johns Hopkins School of Medicine. Baltimore, MD.
Undergraduate Internship: Inpatient Substance Abuse Treatment. 1/95-5/95
Massey Substance Dependence Unit, Joseph B. Finnan Center Cumberland, MD.
PEER-REVIEWED PUBLICATIONS
Clement, C.L., Marlowe, D.B., Patapis, N.S., Festinger, D.S., & Forman, R.F. (2012). Nonprescription
steroids on the Internet. Substance Use and Misuse, 47(3), 329-341.
Marlowe, D. B., DeMatteo, D. S., Patapis, N. S., & Festinger, D. S. (2012). Forensic assessment of
substance abuse. In S. Anderer (Ed.), Coping with psychiatric and psychological testimony (6th
ed.). New York: Oxford University Press.
Marlowe, D., Festinger, D., Arabia, P., Croft, J., Patapis, N. S. & Dugosh, K. (2009). A Systematic
Review of DWI Court Program Evaluations. Drug Court Review (2), 11-57.
Patapis, N. S., & Marlowe, D. B. (2008). Drugs of Abuse. In W. A. Darity (Ed.). International
Encyclopedia of the Social Sciences, 2nd Edition. McMillan Reference USA: Detroit, MI.
Hover, V., Marlowe, D., & Patapis, N. et al., (2008). Internet access to Salvia divinorium: implications
for policy, practice. Journal of Substance Abuse treatment, 35(1), 22-27.
Belenko, S. B., & DeMatteo, D. S., Patapis, N. S. (2007). Drug courts. In A. R. Roberts & D. W.
Springer (Eds.), Forensic social work in juvenile and criminal justice: An evidence-based handbook.
Springfield, IL: Charles C. Thomas Pub., Ltd.
Festinger, D. F., Ratanadilok, K., Marlowe, D. B., Dugosh, K. L., Patapis, N. P., & DeMatteo, D. S.
(2007). Retention and understanding of informed consent with and without corrected-feedback.
Ethics and Behavior, 31, 560-575.
Marlowe, D. B., DeMatteo, D. S., Festinger, D. S., & Patapis, N. S. (2007). Drug dependence is
omnigenus: The disease analogy and criminal justice policy. In K. Knight & D. Farabee (Eds.)
Treating addicted offenders: a continuum of effective practices, Vol. II.
Patapis, N. S., & McDonald, C. L. (2007). WebSafePhilly: Alerting Parents to Narcotics on the Net.
Treatment Research Institute: Philadelphia, PA.
Loving, J. L., & Patapis, N. (2007). Juvenile waiver and reverse waiver: integrating statues and case
law into clinical practice. Journal of Forensic Psychology Practice, 7, 67-78.
Patapis, N. & Nordstrom, B. R. (2006). Naltrexone research in the criminal justice system. Journal of
Substance Abuse Treatment, 31, 113-115.
5. N. Patapis. 5
Marlowe, D. B., Festinger, D. S., Foltz, C., Lee, P. A., & Patapis, N. S. (2005). Perceived deterrence
and outcomes in drug court. Behavioral Sciences and the Law, 23, 183-198.
McKay, J. R., Franklin, T., Patapis, N. S., & Lynch, K. (2005). Conceptual, methodological, and
analytical issues in the study of relapse. Clinical Psychology Review, 26 (2), 109-107.
Festinger, D. S., Marlowe, D. B., Croft, J. S., Dugosh, K., Mastro, N., Lee, P., DeMatteo, D. S., &
Patapis, N. S. (2005). Do research payments precipitate drug use or coerce participation? Drug
and Alcohol Dependence. 78, 275-281.
Marlowe, D. B., DeMatteo, D. S., Festinger, D. S., & Patapis, N. S. (2004). Drug dependence is
omnigenus: The disease analogy and criminal justice policy. Offender Substance Abuse Report, 4,
65-78.
Marlowe, D. B., Patapis, N. S., & DeMatteo, D. S. (2003). Amenability to treatment of drug
offenders. Federal Probation: A Journal of Correctional Philosophy and Practice, 67, 40-46.
Belenko, S., Patapis, N. S., & French, M. T. (2005). The economic benefits of drug treatment: A
critical review of the evidence for policy makers. National Rural Institute on Drug and Alcohol
Abuse: Washington, D.C.
PEER REVIEWED PRESENTATIONS
Patapis, N. S., McDonald, C. M., & Festinger, D. S. (2008). Evaluating a parent workshop to prevent
children's access to prescription narcotics on the Internet. Poster session presented at the 70th
Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, PR.
Festinger, D. S., Marlowe, D. B., Croft, J. R., Dugosh, K. L., Benasutti, K. M., Patapis, N.S., & Lee-
Arabia, P. L. (June, 2007). Do research intermediaries reduce perceived coercion in drug court
research? Presentation to the 69th Annual Scientific Meeting of the College on Problems of Drug
Dependence (CPDD), Quebec, Canada.
McDonald, C. L., Marlowe, D. B., Patapis, N. S., Festinger, D. S., & Forman, R. F. (June, 2007).
Nonprescription steroids on the Internet. Presentation to the 69th Annual Scientific Meeting of
the College on Problems of Drug Dependence (CPDD), Quebec, Canada.
Pich, M. L., McDonald, C. L., James, Patapis, N. S., Festinger, D. S., & Marlowe, D. B. (June, 2007)
Frequency of illicit drug promotion through the Internet. Presentation to the 69th Annual
Scientific Meeting of the College on Problems of Drug Dependence (CPDD), Quebec, Canada.
Festinger, D., Ratanadilok, K., Patapis, N., Dugosh, K., Bennesutti, K., & Marlowe, D. (June, 2006)
Neuropsychological functioning and retention of research consent information. Presentation to
the 68th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD),
Scottsdale, AZ.
Marlowe, D., Festinger, D., Lee, P., Dugosh, K., Benasutti, K., DeMatteo, D., & Patapis, N. (August,
2006) Experimental Research on Judicial Supervision in Drug Courts. Presentation to the 114th
Annual Conference of the American Psychological Association (APA). New Orleans, LA.
Ratanadilok, K., Goldberg, K., Masterpasqua, F., Harver, W.E., Patapis, N. S., & Festinger, D. (June,
2006). Neuropsychological correlates to treatment progress in substance abuse offenders. Poster
session presented at the American Academy of Clinical Neuropsychology (AACN) Annual
Conference, Philadelphia, PA.
6. N. Patapis. 6
Ratanadilok, K., Festinger, D., Patapis, N., Goldberg, K., & Marczyk, G. (October, 2005).
Neuropsychological correlates to treatment progress in substance abusing offenders.
Presentation to the Annual Conference of the National Academy of Neuropsychology (NAN),
Tampa Bay, FL.
Patapis, N. S. & Belenko, S. (2005) An economic evaluation of drug abuse treatment. Presentation
to the 67th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD),
Orlando, FL.
Festinger, D. S., Marlowe, D. B., DeMatteo, D. S., Croft, J. R., Lee, P. A., & Patapis, N. S. (2004, June).
Graphical performance feedback in drug court. In A. T. McLellan (Chair), Five easy pieces:
Examples of science-based clinical interventions designed for practical application in real-world
settings. Symposium presented to the 66th Annual Scientific Meeting of the College on Problems
of Drug Dependence (CPDD), San Juan, Puerto Rico.
Festinger, D. S., Marlowe, D. B., Lee, P. A., DeMatteo, D. S., & Patapis, N. S. (June, 2004). Ethics of
participant payment in substance abuse research. Paper session presented at the 66th Annual
Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, Puerto Rico.
Festinger, D. S., Marlowe, D. B., Lee, P. A., Fox, G., Alexander, R. K., Mastro, N. K., Patapis, N. S. &
DeMatteo, D. S. (November, 2004). Do enhanced rewards improve outcomes in drug court?
Presentation to the Addiction Health Services Research Conference (AHSRC), Philadelphia, PA.
Festinger, D. S., Marlowe, D. B., Lee, P. A., Fox, G., Alexander, R. K., Mastro, N. K., Patapis, N. S. &
DeMatteo, D. S. (2004, October). Matching judicial supervision to client risk status in drug courts.
Paper presented at the 2004 Addiction Health Services Research Conference (AHSR),
Philadelphia, PA.
Festinger, D., DeMatteo, D., Marlowe, D., Lee, P., & Patapis, N. (2004, March). Expungement in drug
court programs: Do clients know what they’re missing? Paper Presented at the 2004 Annual
Conference of the American Psychology-Law Society (AP-LS)/Div. 41 of the American
Psychological Association (APA), Scottsdale, AZ.
Marlowe, D. B., Festinger, D. S., Lee, P. A., DeMatteo, D. S., Patapis, N. S., Mastro, N. K., Benasutti,
K. M., & Johle, M. C. (2004, June). Matching judicial supervision to clients’ risk status in drug
court. Poster session presented to the 66th Annual Scientific Meeting of the College on Problems
of Drug Dependence (CPDD), San Juan, Puerto Rico.
Marlowe, D., Festinger, D., Lee, P., DeMatteo, D., & Patapis, N. (2004, March) Examining the role of
the judge in drug court. Paper Presented at the 2004 Annual Conference of the American
Psychology-Law Society (AP-LS)/Div. 41 of the American Psychological Association (APA),
Scottsdale, AZ.
Patapis, N. S., DeMatteo, D. S., Marlowe, D. B., & Festinger, D. S. (2004, March). Amenability to
treatment of juvenile offenders: Legal vs. clinical conceptualizations. Poster session presented at
the 2004 Annual Conference of the American Psychology-Law Society (AP-LS)/Div. 41 of the
American Psychological Association (APA), Scottsdale, AZ.
DeMatteo, D. S., Marlowe, D. B., Festinger, D., Lee, P. A., McLellan, A. T. & Patapis, N. S. (2003,
June). A behavioral measure of motivation for drug abuse treatment. Poster session presented
at the 65th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), Bal
Harbour, FL.
Loving, J., Lipkin, N., Patapis, N., & Russell, W. (January, 2001) Assessing psychopathy in girls:
Conceptual issues and preliminary Psychopathy Checklist: Youth Version findings. Paper presented
at the 2001 Meeting of the Society for Personality Assessment (SPA).
7. N. Patapis. 7
AWARDS
Ruth L. Kirschstein National Research Service Award (NIH, 2002)
NIH Student Loan Repayment Award for Clinical-Researchers
NIH Loan Repayment Award for Clinical-Researchers, Competitive Renewal
Pennsylvania Department of Health Grant #100707-T
APA Early Career Training Award (2006, Computers & Technology)
ACADEMIC HONORS
Magna Cum Laude (Psy.D.)
Psi Chi National Honor Society in Psychology